BPC-157 (Pentadecapeptide)

The Proline Problem in BPC-157 Synthesis

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-232 cited sources

The short answer

Proline coupling is sterically hindered and is a recognised difficult step in solid-phase peptide synthesis. BPC-157 has four prolines with three consecutive, which makes it a harder synthesis than its length suggests and gives purity figures particular significance.

Key facts

Prolines
Four, three consecutive
Synthesis method
Solid-phase (SPPS)
Difficulty
Proline coupling is sterically hindered
Consequence
Higher risk of deletion sequences
Aggregation risk
Polyproline segments can complicate coupling
Practical effect
Purity figures deserve scrutiny

How solid-phase synthesis works

The peptide is built one residue at a time on a solid resin, C-terminus first. Each cycle couples the next protected amino acid, then removes its protecting group to expose the amine for the next. Coupling is never quite 100% efficient, and any chain that fails to react in a cycle produces a deletion sequence, a peptide missing one residue, which persists through the rest of the synthesis.

Why proline is difficult

Proline's side chain loops back onto its own backbone nitrogen, making that nitrogen a secondary rather than primary amine and surrounding it with more steric bulk. Both effects slow coupling. A residue that couples slowly gets less complete conversion in the time available, which means more deletion sequences than an unhindered residue would produce.

Research material referenced

BPC-157 5mg, third-party HPLC tested

Buy BPC-157 · £16.95

Why consecutive prolines compound it

Coupling onto a proline is harder than coupling onto most residues, because the resulting secondary amide constrains the growing chain. Three prolines in a row means three consecutive difficult couplings, each inheriting whatever incompleteness preceded it. Polyproline segments can also promote chain aggregation on the resin, which further reduces accessibility.

What this means for a purity figure

For a short, unhindered peptide a high purity figure is close to automatic. For BPC-157 it reflects real process control. That makes the figure more informative here than it would be for a heptapeptide, and it makes an unexpectedly low one a real signal rather than an anomaly. A visible chromatogram matters correspondingly more.

Where deletion sequences show up

On a mass spectrum, as species lighter than the parent by exactly one residue's mass. A missing proline shows as −97 Da, a missing glycine as −57. These are close enough to the parent to require adequate resolution but far enough to be unambiguous when it is present.

Frequently asked questions

Why is BPC-157 harder to synthesise than its length suggests?

Four prolines, three of them consecutive. Proline coupling is sterically hindered and slower, producing more deletion sequences.

What is a deletion sequence?

A peptide missing one residue, produced when a coupling step fails to go to completion. It persists through the rest of the synthesis.

How would I spot one?

On a mass spectrum, as a species lighter than the parent by exactly one residue, 97 Da for a missing proline, 57 for glycine.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More BPC-157 (Pentadecapeptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.